Efeitos pleiotrópicos das estatinas na sepse
Kelly Cristina Batista de Souto Queiroz +4 more
core +1 more source
The efficacy of preoperative evolocumab-rosuvastatin combination therapy in patients with ST-elevation myocardial infarction. [PDF]
Li H, Dong H, Bao S, Wang X, Fu Z.
europepmc +1 more source
Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial. [PDF]
Nicholls SJ +8 more
europepmc +1 more source
Long-term benefits of atorvastatin on the incidence of cardiovascular events: the ASCOT-Legacy 20-year follow-up. [PDF]
Sever PS +10 more
europepmc +1 more source
Use and effectiveness of PCSK-9 inhibitors in heart diseases: A review. [PDF]
Alorfi NM +5 more
europepmc +1 more source
PCSK9 inhibitors in real life-Cardiometabolic risk management in dyslipidemic patients in Vienna. [PDF]
Ferch M +4 more
europepmc +1 more source
Protocol for a systematic review and meta-analysis of the combination of ezetimibe and statins for hyperlipidemia. [PDF]
Yang T +5 more
europepmc +1 more source
Effect of Probucol and Atorvastatin Treatment on the Self-Care Ability of Acute Cerebral Infarction Patients: A Randomized Clinical Trial Study. [PDF]
Yu N +6 more
europepmc +1 more source
Causal Relationship Between the Abuse of Cholesterol-Lowering Medication, Blood Pressure Medication, Insulin, and Exogenous Hormones and Cerebral Infarction. [PDF]
Liu J, Lv D, Li S, An Z, He Z, Liu Y.
europepmc +1 more source
Role of PCSK9 inhibitors in venous thromboembolism: current evidence and unmet clinical needs. [PDF]
Zuin M +14 more
europepmc +1 more source

